Ascentage Pharma Group International (FRA:36X)
Germany flag Germany · Delayed Price · Currency is EUR
6.45
-0.15 (-2.27%)
At close: Dec 5, 2025

FRA:36X Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Market Capitalization
2,5831,750900796819896
Upgrade
Market Cap Growth
63.94%94.41%13.02%-2.79%-8.59%28.23%
Upgrade
Enterprise Value
2,5911,831913777702855
Upgrade
Last Close Price
6.455.602.842.962.843.68
Upgrade
PS Ratio
55.6313.4831.7827.99212.05574.86
Upgrade
PB Ratio
32.1548.2399.8714.364.798.45
Upgrade
P/TBV Ratio
38.1080.87-19.595.159.47
Upgrade
EV/Sales Ratio
54.8114.1132.2427.31181.70548.17
Upgrade
Debt / Equity Ratio
2.546.0925.424.390.880.63
Upgrade
Asset Turnover
0.130.380.080.070.010.01
Upgrade
Inventory Turnover
3.702.562.383.29--
Upgrade
Quick Ratio
1.401.171.351.785.053.77
Upgrade
Current Ratio
1.541.261.441.865.223.91
Upgrade
Return on Equity (ROE)
-159.65%-235.32%-386.28%-107.45%-75.18%-78.02%
Upgrade
Return on Assets (ROA)
-22.77%-9.25%-20.92%-19.14%-24.97%-29.14%
Upgrade
Return on Capital (ROIC)
-28.78%-12.43%-27.41%-24.43%-31.57%-36.13%
Upgrade
Return on Capital Employed (ROCE)
-62.00%-26.10%-57.00%-45.30%-36.20%-47.00%
Upgrade
Earnings Yield
-5.33%-3.07%-13.12%-15.04%-13.22%-9.47%
Upgrade
FCF Yield
-1.00%-1.03%-10.95%-14.60%-17.57%-12.02%
Upgrade
Buyback Yield / Dilution
-12.40%-7.00%-7.07%-3.56%-17.93%-84.97%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.